Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1251 - 1258 of 1258

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1426 - 1450 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Reimbursement of Newer Drugs for Type 2 Diabetes in Canada: An Environmental Scan		Feb 26, 2019	Health Technology Review	Environmental Scan	Completed	ES0337-000
CADTH Pharmaceutical Reviews Update — Issue 5		Feb 20, 2019	Reimbursement Review	Pharmaceutical Review Update
ertugliflozin	SR0565 Steglatro - CDEC Final Recommendation January 25, 2019 for posting.pdf sr0565-steglatro-clinical-report.pdf sr0565-steglatro-pharmacoeconomic-report.pdf sr0565-steglatro-patient-input.pdf	Feb 8, 2019	Reimbursement Review		Complete	SR0565-000
ertugliflozin and metformin	SR0566 Segluromet - CDEC Final Recommendation January 25, 2019 for posting.pdf sr0566-segluromet-combined-report.pdf	Feb 7, 2019	Reimbursement Review		Complete	SR0566-000
sucroferric oxyhydroxide	SR0571 Velphoro - CDEC Final Recommendation January 4, 2019 for posting.pdf sr0571-velphoro-clinical-report.pdf sr0571-velphoro-pharmacoeconomic-report.pdf sr0571-velphoro-patient-input.pdf	Feb 1, 2019	Reimbursement Review		Complete	SR0571-000
lixisenatide + insulin glargine	SR0564 Soliqua - CDEC Final Recommendation January 3, 2019 for posting.pdf sr0564-soliqua-clinical-report.pdf sr0564-soliqua-pharmacoeconomic-report.pdf sr0564-soliqua-patient-input.pdf	Jan 30, 2019	Reimbursement Review		Complete	SR0564-000
fluticasone propionate	SR0539 Aermony RespiClick - CDEC Final Recommendation for posting December 21, 2018.pdf sr0539-aermony-respiclick-clinical-report.pdf sr0539-aermony-respiclick-pe-report.pdf sr0539-aermony-respiclick-PI-submissions.pdf	Jan 21, 2019	Reimbursement Review		Complete	SR0539-000
Tagrisso for Non-Small Cell Lung Cancer (first line) – Details	pcodr_provfund_osimertinib_tagrisso_nsclc_1ln.pdf 10137OsimertinibNSCLC_FnRec_2019-01-02_ChairApproved_Post_04Jan2019_final.pdf 10137OsimertinibNSCLC_fnCGR_NOREDACT_Post_04Jan2019_final.pdf 10137OsimertinibNSCLC_fnEGR_NOREDACT-ABBREV_Post_04Jan2019_final.pdf pcodr_osimertinib_tagrisso_nsclc_1stln_in_rec.pdf 10137_Osimertinib_NSCLC_1L_PAGFeedbackSummary_FINAL_Post_04Jan2019_final.pdf 10137OsimertinibNSCLC(firstline)_SubmitterFeedback_2018-11-15_Post_04Jan2019_final.pdf 10137OsimertinibNSCLC(firstline)_PatientGroupFeedback_LCC_2018-11-15_Post_04Jan2019_final.pdf 10137OsimertinibNSCLC(firstline)_ClinicianFeedback_Combined_Post_04Jan2019_Redacted_final_Redacted.pdf 10137OsimertinibNSCLC_COI_LCC_2018-05-31_Post_04Jan2019_final_Redacted.pdf 10137OsimertinibNSCLC_COI Combined_Post_04Jan2019_final.pdf	Jan 21, 2019	Reimbursement Review		Complete	PC0137-000
benralizumab	SR0561_Fasenra_Aug_23_18.pdf SR0561_Fasenra_CL_Report.pdf SR0561_Fasenra_PE_Report.pdf SR0561_Fasenra_PI_Submissions.pdf	Jan 16, 2019	Reimbursement Review		Complete	SR0561-000
Tisagenlecleucel (Kymriah) for Pediatric Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma	media:document:d00ebe66-c3ca-4630-a5c9-9db0789e0f05 media:document:d878e503-9902-4b9a-b462-1c08b76ea345 media:document:db2f1690-ae45-427b-926d-e7e0b29a66b6	Jan 15, 2019	Health Technology Review	Optimal Use	Completed	OP0538-000 / CT0001
Tisagenlecleucel for Acute Lymphoblastic Leukemia and Diffuse Large B-cell Lymphoma: Recommendations		Jan 15, 2019	Health Technology Review	Optimal Use	Completed	OP0538-000 / CT0001
nitisinone	SR0538_cdr_complete_MDK_Nitisinone_Apr_27_18_e.pdf SR0538_MDK_Nitisinone_CL_Report.pdf SR0538_MDK_Nitisinone_PE_Report.pdf SR0538_MDK_Nitisinone_PI_Submissions.pdf	Jan 14, 2019	Reimbursement Review		Complete	SR0538-000
Mvasi for Metastatic Colorectal Cancer / Non-Small Cell Lung Cancer Biosimilar – Details	pcodr_provfund_10158_bevacizumab_mvasi_mcrc_nsclc.pdf 10158MVASI_CADTHBiosimilarSummaryDossier_FINAL_14Jan2019.pdf	Jan 14, 2019	Reimbursement Review		Complete	PC0158-000
Levodopa / carbidopa (Drug Plan Submission)	SR0557_Duodopa_Aug_24-18.pdf SR0557_DuodopaFWG_CL_Report.pdf SR0557_DuodopaFWG_PE_Report.pdf SR0557_Duodopa_PI_Submissions.pdf si0001-duodopa-drug-implementation-advice.pdf	Jan 14, 2019	Reimbursement Review		Complete	SR0557-000
Detection and Diagnosis of Sepsis in Rural and Remote Areas: An Environmental Scan		Jan 9, 2019	Health Technology Review	Environmental Scan	Completed	ES0327-000
Rivaroxaban	SR0569 Xarelto - Confidential Final CDEC Recommendation (redacted)_for posting.pdf SR0569_Xarelto_CL_Report.pdf SR0569_Xarelto_PE_Report.pdf	Jan 3, 2019	Reimbursement Review		Complete	SR0569-000
cladribine	SR0546-Mavenclad_Oct-26-18.pdf SR0546_Mavenclad_CL_Report.pdf SR0546_Mavenclad_PE_Report.pdf SR0546_Mavenclad_PI_Submissions.pdf	Dec 21, 2018	Reimbursement Review		Complete	SR0546-000
ozenoxacin	SR0553_Ozanex_Oct-26-18.pdf SR0553_Ozanex_CL_Report.pdf SR0553_Ozanex_PE_Report.pdf SR0553_Ozanex_PI_Submissions.pdf	Dec 21, 2018	Reimbursement Review		Complete	SR0553-000
bictegravir/emtricitabine/tenofovir alafenamide	SR0567 Biktarvy - CDEC Final Recommendation October 29, 2018.pdf SR0567_Biktarvy_CL_Report.pdf SR0567_Biktarvy_PE_Report.pdf SR0567_Biktarvy_PI_Submissions.pdf	Dec 21, 2018	Reimbursement Review		Complete	SR0567-000
sebelipase alfa	SR0544 Kanuma - CDEC Final Recommendation September 28, 2018.pdf SR0544_Kanuma_CL_Report.pdf SR0544_Kanuma_PE_Report.pdf SR0544_Kanuma_PI_Submissions.pdf si0003-kanuma-cadth-drug-implementation-advice.pdf	Dec 21, 2018	Reimbursement Review		Complete	SR0544-000
Tapentadol Hydrochloride	SR0563_Nucynta - CDEC Final Recommendation October 25, 2018.pdf SR0563_Nucynta_CL_Report.pdf SR0563_Nucynta_PE_Report.pdf SR0563_Nucynta_PI_Submissions.pdf	Dec 21, 2018	Reimbursement Review		Complete	SR0563-000
dexamethasone	SR0535_Ozurdex_Oct-26-18.pdf SR0535_Ozurdex _CL_Report.pdf SR0535_Ozurdex_PE_Report .pdf SR0535_Ozurdex_PI_Submissions.pdf	Dec 21, 2018	Reimbursement Review		Complete	SR0535-000
Opdivo for Hepatocellular Carcinoma – Details	pcodr_provfund_nivolumab_opdivo_hcc.pdf pcodr_nivolumab_opdivo_hcc_fn_rec.pdf pcodr_nivolumab_opdivo_hcc_fn_cgr.pdf pcodr_nivolumab_opdivo_hcc_fn_egr.pdf pcodr_nivolumab_opdivo_hcc_in_rec.pdf pcodr_nivolumab_opdivo_hcc_pagfdk.pdf pcodr_nivolumab_opdivo_hcc_bmsc.pdf pcodr_nivolumab_opdivo_hcc_clnfdk.pdf pcodr_nivolumab_opdivo_hcc_coi_pt.pdf pcodr_nivolumab_opdivo_hcc_coi_cln.pdf	Dec 14, 2018	Reimbursement Review		Complete	PC0134-000
Perjeta-Herceptin Combo Pack for Early Breast Cancer – Details	pcodr_provfund_10127perjeta-herceptin-combo_ebc.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_fn_rec.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_fn_cgr.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_fn_egr.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_in_rec.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_pagfdk.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_hlr.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_ptfdk.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_clnfdk.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_coi_pt.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_coi_cln.pdf	Dec 14, 2018	Reimbursement Review		Complete	PC0127-000
CADTH Pharmaceutical Reviews Update — Issue 4		Dec 13, 2018	Reimbursement Review	Pharmaceutical Review Update